Alentis Therapeutics AG
Edit

Alentis Therapeutics AG

https://alentis.ch/
Last activity: 08.08.2023
Categories: UniversityHealthTechDevelopmentBioTechResearchPlatform
Alentis Therapeutics is a Swiss-based biotechnology company with R&D activities in France that focuses on the development of highly innovative treatments for fibrotic diseases using monoclonal antibodies targeting Claudin-1.
Mentions
30
Location: Switzerland, Basel-City, Basel
Total raised: $185.66M

Investors 3

Funding Rounds 3

DateSeriesAmountInvestors
14.04.2023Series C$105MJeito Capi...
15.06.2021Series B$67M-
30.04.2019Series A$13.66M-

Mentions in press and media 30

DateTitleDescriptionSource
13.07.2023Startups gather Board members’ expertise Versameb is transforming (m)RNA therapeutics to cure hard-to-treat and/or prevalent diseases with ...startuptic...
15.06.2023Alentis gets FDA green light to enter the oncology sector Alentis Therapeutics is developing a portfolio of first-in-class anti-CLDN1 monoclonal antibodies ...startuptic...
10.05.2023Biotech startups turn gear into Phase 2 clinical trials Bioversys focuses on the research and development of small molecules for multidrug-resistant bacte...startuptic...
28.04.2023Swiss Accelerator: Innosuisse supports 53 companies with CHF... As Switzerland is not currently associated with the EU’s Horizon Europe framework programme, Swiss...startuptic...
14.04.2023Switzerland-based Alentis Therapeutics raises USD 105 millio...Basel, Switzerland-based clinical-stage biotech developing breakthrough treatments for organ fibrosi...vcbay.news...
13.04.2023Alentis Therapeutics closes $105 million Series C funding to...April 13, 2023 Proceeds will fund: Basel, Switzerland – 13 April 2023, Alentis Therapeutics (“Alen...htgf.de/en...
13.04.2023Alentis Therapeutics Raises US$105M in Series C FundingAlentis Therapeutics, a Basel, Switzerland-based clinical-stage biotech developing breakthrough trea...finsmes.co...
13.04.2023Alentis rides in zolbetuximab's slipstream to secure $105M s...The string of recent clinical successes for the antibody zolbetuximab has not only been welcome good...fiercebiot...
13.04.2023Alentis Therapeutics Lands $105M for Clinical Trials in Fibr...Alentis Therapeutics, a biotech pursuing a novel target as a way of treating fibrosis and cancer, ha...medcitynew...
13.04.2023Alentis secures USD 105 million to boost development of its ...Alentis secures USD 105 million to boost development of its cancer-treatment platform 13.04.2023 09:...venturelab...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In